Virtual meeting via WebEx, October 8-9, 2020
This workshop will be invitational only
Speakers
Keynote Speakers
Norman E. Sharpless, MD
Director
NCI
Douglas R. Lowy, MD
Principal Deputy Director
NCI
Anand Shah, MD
Deputy Commissioner for Medical and Scientific Affairs
FDA
Diana Espinosa, MPP
Deputy Administrator
HRSA
Shari M. Ling, MD
Deputy Chief Medical Officer
CMS
Presenters listed in alphabetical order
Philip Castle, PhD, MPH
Director, Division of Cancer Prevention
NCI
Christopher Hartshorn, PhD
Program Director, Division of Cancer Treatment and Diagnosis
NCI
Fasiha Kanwal, MD, MSHS, AGAF
Chief, Section of Gastroenterology and Hepatology
Baylor College of Medicine
Erin Kobetz, PhD, MPH
Associate Director, Population Science and Cancer Disparity
University of Miami
Marina Kondratovich, PhD
Associate Director, Center for Devices and Radiological Health
FDA
Graham Lidgard, PhD
Chief Science Officer
Exact Sciences Corporation
Rohit Loomba, MD
Professor of Medicine
University of California San Diego
Catherine Marinac, PhD
Member of Faculty
Dana-Farber Cancer Institute
David McConkey, PhD
Director
Johns Hopkins Greenberg Bladder Cancer Institute
Jacqueline Miller, MD, CAPT
US Public Health Service, Medical Director
CDC
George Netto, MD
Chair of Pathology
University of Alabama at Birmingham
Geoffrey Oxnard, MD
Medical Oncologist
Foundation Medicine Inc.
Nickolas Papadopoulos, PhD
Professor of Oncology
Johns Hopkins University School of Medicine
Henry Rodriguez, PhD, MBA
Director, Office of Cancer Clinical Proteomics Research
NCI
Sonia Rosenfield, PhD
Health Science Administrator, Center for Research Strategy
NCI
Charles Rosser, MD, MBA
Medical Director, Cancer Clinical Trials Office
Cedars-Sinai
Vikrant Sahasrabuddhe, MBBS, DrPH
Program Director, Division of Cancer Prevention
NCI
Mona Saraiya, MD, MPH
Medical Epidemiologist
NCI and CDC
Mark Schiffman, MD, MPH
Senior Investigator, Division of Cancer Epidemiology and Genetics
NCI
Johannes Schweizer, PhD
Chief Science Officer
Arbor Vita
Ashim Subedee, PhD
Academic Innovation Lead, Small Business Education and Entrepreneurial Development
NIH OER
Živana Težak, PhD
Associate Director, Center for Devices and Radiological Health
FDA
Robin Vanderpool, DrPH
Branch Chief, Division of Cancer Control and Population Sciences
NCI
Shan Wang, PhD
Professor
Stanford University
Xin Wei Wang, PhD
Deputy Chief, Center for Cancer Research
NCI
LeeAnn Bailey, PhD
Branch Chief, Center to Reduce Cancer Health Disparities
NCI
Sabrina Matoff-Stepp, PhD
Senior Advisor, Office of Planning, Analysis, and Evaluation
HRSA
Anand Pathak, PhD, MD, MPH
Medical Officer, Center for Devices and Radiological Health
FDA
Peter Delnero, PhD, MPH
Cancer Prevention Fellow
NCI
Rao Divi, PhD
Program Director, Division of Cancer Control and Population Sciences
NCI
Tiffany Gillis-Brown, JD
Public Health Analyst
HRSA
Tara Hiltke, PhD
Program Director, Office of Cancer Clinical Proteomics Research
NCI
Mark Lowry, PhD, MA
Cancer Research Training Award Fellow
NCI
Camella Rising, PhD, MS, RDN
Cancer Research Training Award Fellow
NCI
Tony Dickherber, PhD
Program Director, Center for Strategic Scientific Initiatives; Director, Innovative Molecular Analysis Technologies Program
NCI
Xing-Jian Lou, PhD
Program Director, SBIR Development Center
NCI
Richard Mazurchuk, PhD
Program Director, Division of Cancer Prevention
NCI